ArticleFrontiers in pediatrics2026
Accidental alcohol ingestion triggering severe disulfiram-like reaction in a child receiving cefoperazone-sulbactam: a rare case report.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Ethanol as a Modifier of Drug Toxicity in Humans: Pathways of Toxicity and Organ-Level Consequences.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The disulfiram-like reaction (DLR) is a potentially life-threatening adverse drug reaction triggered by concomitant alcohol exposure during treatment with certain medications, particularly cephalosporins containing a methyltetrazolethiol (MTT) side chain such as cefoperazone-sulbactam. It is well-documented in adults, however pediatric cases are rarely reported. Case presentation: We report the case of a 4-year-old boy hospitalized with bronchopneumonia who received intravenous cefoperazone-sulbactam for 7 days with good clinical response. On the 8th day of hospitalization, approximately 10 min after accidentally consuming a small amount of an alcoholic beverage (RIO cocktail, 3%-8% vol), and during the subsequent cefoperazone-sulbactam infusion, the child suddenly developed generalized rash, facial flushing, drowsiness, dyspnea, hypotension (70/50 mmHg), tachycardia (180 beats/min), and prolonged capillary refill time (3 s), consistent with shock. Initially suspected as anaphylactic shock, cephalosporin-induced disulfiram-like reaction (CIDLR) was proposed after the parents revealed the accidental alcohol ingestion. The child was successfully resuscitated with immediate drug discontinuation, oxygen supplementation, fluid resuscitation, and dexamethasone administration. All symptoms resolved within hours, and the child was discharged home two days later with no sequelae at two-week follow-up. Conclusion: Although the clinical manifestations and temporal association with accidental alcohol ingestion in this case are most consistent with a disulfiram-like reaction, definitive diagnosis is limited by the lack of objective alcohol quantification, and a hypersensitivity reaction cannot be completely excluded. Clinicians should remain alert to both disulfiram-like reactions and hypersensitivity reactions in children receiving cefoperazone-sulbactam, and strict education regarding alcohol avoidance should be provided to caregivers to prevent life-threatening adverse events.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.